betamoxillin
biomedical pharmaceutical industries-egypt - amoxicillin trihydrate 57.4 gm eq. to amoxicillin base 50 gm /100gm - water soluble powder
metabolade scour dehydration therapy for calves & pigs
aventis animal nutrition pty ltd - electrolyte supplement
metabolase veterinary
romat ltd - acetylmethionine 20 mg/ml; arginine 2.4 mg/ml - solution for injection - supplement of vitamins, amino acid and sugars
metabolase forte
fatro s.p.a - acetyl-dl-methionine; l-carnitine hydrochloride; vitamin b12; vitamin e acetate (dl mix rac) - acetyl-dl-methionine 200 g/litre; l-carnitine hydrochloride 61.3 g/litre; vitamin b12 0.2 g/litre; vitamin e acetate (dl mix rac) 33 g/litre - parenteral nutrient/electrolyte
metabolase veterinary
romat ltd - aspartic acid; cyanocobalamin; d, l-acetylmethionine; fructose; glutamic acid; glycine; l- citrulline; l- lysine as hydrochloride; l- ornithine as hydrochloride; l-arginine; l-carnitine as hydrochloride; pyridoxine (vit b6) hydrochloride; sorbitol; thioctic acid - solution for injection - thioctic acid 0.2 mg/ml; cyanocobalamin 0.03 mg/ml; glycine 1.5 mg/ml; aspartic acid 1.5 mg/ml; glutamic acid 1.5 mg/ml; fructose 50 mg/ml; sorbitol 80 mg/ml; pyridoxine (vit b6) hydrochloride 0.15 mg/ml; l- ornithine as hydrochloride 1.20 mg/ml; l- lysine as hydrochloride 0.50 mg/ml; l- citrulline 1.20 mg/ml; l-carnitine as hydrochloride 5.00 mg/ml; l-arginine 2.40 mg/ml; d, l-acetylmethionine 20.00 mg/ml - supplement of vitamins, amino acid and sugars
vitascience sugar metabolaid
vitahealth laboratories australia pty ltd - alpha lipoic acid,chromic chloride hexahydrate,chromium picolinate,colecalciferol,cinnamomum cassia,gymnema sylvestre,nicotinamide,trigonella foenum-graecum,zinc amino acid chelate -
dovate ointment 2.5mg
aspen pharmacare - clobetazol propionate - ointment - clobetazole propionate 2.5mg/5g
nizatidine capsule
actavis pharma, inc. - nizatidine (unii: p41pml4ghr) (nizatidine - unii:p41pml4ghr) - nizatidine 150 mg - nizatidine is indicated for up to 8 weeks for the treatment of active duodenal ulcer. in most patients, the ulcer will heal within 4 weeks. nizatidine is indicated for maintenance therapy for duodenal ulcer patients, at a reduced dosage of 150 mg h.s. after healing of an active duodenal ulcer. the consequences of continuous therapy with nizatidine for longer than 1 year are not known. nizatidine is indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis, including erosive and ulcerative esophagitis, and associated heartburn due to gerd. nizatidine is indicated for up to 8 weeks for the treatment of active benign gastric ulcer. before initiating therapy, care should be taken to exclude the possibility of malignant gastric ulceration.